Cargando…
Pimecrolimus cream in the management of patients with atopic eczema
Atopic eczema is a common pediatric skin disorder. This review examines the use of pimecrolimus cream in the treatment of acute and chronic stages of the disease. The standard therapy is the treatment of acute flares with topical medications including pimecrolimus. The use of pimecrolimus cream for...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047932/ https://www.ncbi.nlm.nih.gov/pubmed/21436971 |
_version_ | 1782199102180687872 |
---|---|
author | Spergel, Jonathan M |
author_facet | Spergel, Jonathan M |
author_sort | Spergel, Jonathan M |
collection | PubMed |
description | Atopic eczema is a common pediatric skin disorder. This review examines the use of pimecrolimus cream in the treatment of acute and chronic stages of the disease. The standard therapy is the treatment of acute flares with topical medications including pimecrolimus. The use of pimecrolimus cream for the first sign and symptoms of atopic eczema reduces the occurrence of flares as defined by the need for topical corticosteroids. The side effects of pimecrolimus cream are mild without any increase of infections or systemic immune suppression. |
format | Text |
id | pubmed-3047932 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-30479322011-03-23 Pimecrolimus cream in the management of patients with atopic eczema Spergel, Jonathan M Clin Cosmet Investig Dermatol Review Atopic eczema is a common pediatric skin disorder. This review examines the use of pimecrolimus cream in the treatment of acute and chronic stages of the disease. The standard therapy is the treatment of acute flares with topical medications including pimecrolimus. The use of pimecrolimus cream for the first sign and symptoms of atopic eczema reduces the occurrence of flares as defined by the need for topical corticosteroids. The side effects of pimecrolimus cream are mild without any increase of infections or systemic immune suppression. Dove Medical Press 2009-05-19 /pmc/articles/PMC3047932/ /pubmed/21436971 Text en © 2009 Spergel, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Review Spergel, Jonathan M Pimecrolimus cream in the management of patients with atopic eczema |
title | Pimecrolimus cream in the management of patients with atopic eczema |
title_full | Pimecrolimus cream in the management of patients with atopic eczema |
title_fullStr | Pimecrolimus cream in the management of patients with atopic eczema |
title_full_unstemmed | Pimecrolimus cream in the management of patients with atopic eczema |
title_short | Pimecrolimus cream in the management of patients with atopic eczema |
title_sort | pimecrolimus cream in the management of patients with atopic eczema |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047932/ https://www.ncbi.nlm.nih.gov/pubmed/21436971 |
work_keys_str_mv | AT spergeljonathanm pimecrolimuscreaminthemanagementofpatientswithatopiceczema |